New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis-Reference-Cited by-同舟云学术

New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis

Published:2003-01 Issue:7 Volume:10 Page:722-733
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Stoeltzing Oliver,Liu Wenbiao,Reinmuth Niels,Parikh Alexander,Ahmad Syed A.,Jung Young D.,Fan Fan,Ellis Lee M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/ASO.2003.07.019.pdf

Reference128 articles.

1. American Cancer Society. Cancer Facts and Figures 2001. Cancer Statistics 2001. Atlanta, GA: American Cancer Society, 2001: 1?44.

2. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59?71.

3. Martin LW, Warren RS. Current management of colorectal liver metastases. Surg Oncol Clin North Am 2000; 9: 853?76,discussion 877?8.

4. Jaeck D, Bachellier P, Weber JC, Mourad M, Walf P, Boudjema K. Surgical treatment of synchronous hepatic metastases of colorectal cancers. Simultaneous or delayed resection (in French)? Ann Chir 1996; 50: 507?12.

5. Scheele J, Stangl R, Schmidt K, Altendorf-Hofmann A. Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis. Chirurg 1995; 66: 965?73.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Angiotensin-Converting Enzyme Inhibitor ‘Enalapril’ Increases the Anti-Proliferative Activity of 5-Fluorouracil in Colorectal Cancer Cells;Eurasian Journal of Medicine and Oncology;2022

2. ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, ENALAPRIL, INHIBITS TUMOR GROWTH AND POTENTIATES THE ANTITUMOR EFFICACY OF 5-FU IN COLORECTAL CANCER;WORLD CANCER RES J;2022

3. 3D Printing and Bioprinting to Model Bone Cancer: The Role of Materials and Nanoscale Cues in Directing Cell Behavior;Cancers;2021-08-12

4. Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer;Molecular Pharmaceutics;2018-05-22

5. Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes;Translational Oncology;2018-04